The most rigorous test possible for developmental totipotency would be significant contributions of the carcinoma cells to the normal differentiation of virtually all tissues in a mouse. For this to occur, the initially malignant cells would presumably have to be brought into association with early embryo cells so that the latter could provide an organizational framework appropriate for normal development. The experiment is analogous to production of allophenic mice (6).
eny. Thus, after almost 200 transplant generations as a highly malignant tumor, embryoid body core cells appear to be developmentally totipotent and able to express, in an orderly sequence in differentiation of somatic and germ-line tissues, many genes hitherto silent in the tumor of origin. This experimental system of "cycling" teratocarcinoma core cells through mice, in conjunction with experimental mutagenesis of those cells, may therefore provide a new and useful tool for biochemical, developmental, and genetic analyses of mammalian differentiation.
The results also furnish an unequivocal example in animals of a non-mutational basis for transformation to malignancy and of reversal to normalcy. The origin of this tumor from a disorganized embryo suggests that malignancies of some other, more specialized, stem cells might arise comparably through tissue disorganization, leading to developmental aberrations of gene expression rather than changes in gene structure.
Teratocarcinoma (or embryonal carcinoma) cells are the malignant stem cells of transplantable mouse teratomas (1, 2) . Some teratomas have been experimentally converted to a modified ascites form, termed "embryoid bodies" (3) . Smallsize embryoid bodies have the advantage over the solid tumors that the location of their embryonal carcinoma cells is known: the latter comprise a "core" (Fig. 3) surrounded by a yolk sac epithelial "rind". Single cells from embryoid bodies are able to form tumors containing various tissues when they are injected subcutaneously (4) . Whether such cells are totipotent has remained unknown, as the solid tumors consistently lack certain tissues (5) .
Abbreviations: PBS, Dulbecco's phosphate-buffered saline; DMEM, Dulbecco's modification of Eagle's medium; FCS, fetal calf serum; GPI, glucosephosphate isomerase; MUP, major urinary protein complex.
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The most rigorous test possible for developmental totipotency would be significant contributions of the carcinoma cells to the normal differentiation of virtually all tissues in a mouse. For this to occur, the initially malignant cells would presumably have to be brought into association with early embryo cells so that the latter could provide an organizational framework appropriate for normal development. The experiment is analogous to production of allophenic mice (6) .
The projected teratoma studies in this laboratory involve the use of mutagenized embryonal carcinoma cells for experimental analyses of genetic regulatory systems in mammalian differentiation (7) . The most promising source of baseline, or nonmutagenized, cells appears to be from the cores of small embryoid bodies grown only in vivo, as these would be less likely to have accumulated genetic changes than would cells cultivated in vitro. Most in vitro teratocarcinoma cell lines do not in fact have a normal chromosome number and some have lost multipotentiality (8) (9) (10) (11) , whereas the tumors from which they originated were diploid (12) .
We report here that teratocarcinoma cells taken from the cores of embryoid bodies grown only in vivo for 8 years, during which they retained a euploid chromosome complement, appear to be developmentally totipotent. The original conversion to malignancy in all likelihood did not involve mutational events and has proved to be completely reversible to normalcy. A partial report of these results has been presented (7).
MATERIALS AND METHODS
Core Cells. The OTT 6050 ascites teratoma, originally received from Dr. L. C. Stevens, has been maintained by intraperitoneal transfers every 2-3 weeks in syngeneic males of the 129/Sv SlJ C P inbred strain (to be referred to as 129) (see Fig. 1 ). To obtain core cells, only small-size embryoid bodies were collected, in Dulbecco's phosphate-buffered saline (PBS), by filtration of ascites fluid through 100 /Am Nitex mesh (13) . They were subjected to light proteolytic treatment for approximately 3 min in 0.25% trypsin (crystalline, Worthington) and 1.25% pancreatin (Difco) in PBS; proteolysis was stopped in Dulbecco's modification of Eagle's medium (DMEM) with 50% fetal calf serum (FCS) (Gibco). Addition of 5 ,gg/ml of DNase eliminated stickiness.
After about 15 min, the embryoid bodies were centrifuged and transferred to DMEM with 15% FCS and organic buffers [10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes) and 10 mM morpholinopropane sulfonic acid (Mops)], and the epithelium was peeled off with tungsten needles. The cores (Fig. 3) were then partially dissociat- (16) and hemoglobin (Hbb locus) (17) . Variants of the major urinary protein complex (MUP) (Mup-1 locus) were analyzed by acrylamide gel electrophoresis (18) . MUP is manufactured in the liver and is normally excreted by mice (19) . The proportions of MUP strain variants detected in the urine of a given allophenic mouse conform to the proportions of the two strains of liver parenchymal cells (but not necessarily of other cell types in the liver), histochemically visualizable by an independent marker; therefore, the liver parenchymal cell genotypes of an allophenic mouse can be indirectly but accurately diagnosed from urinary analyses of its MUP variants (20) . The 7S classes of GI and G2a strain-specific allotypes of immunoglobulins were kindly determined by Dr. Melvin J. Bosma of this Institute, by the Ouchterlony double-diffusion precipitin method. The reagents used (21) are specific for allelic differences at both the Ig-1 and Ig-4 loci. (Fig. 4) The first of these three, mosaic mouse no. I (Fig. 2) , is alive, now (22) (23) (24) (25) . The localized striped areas (Fig. 2) (Fig. 2) , vibrissae, and belly. He has no white areas, but the small white head and belly spot seen in Sil + on some genetic backgrounds (26) are also absent from SIJ/ + controls on the 129 background. The steel phenotype of mouse no. 1 was unexpected because the publication describing the origin of this tumor from a 6-day embryo (3) made no mention of the genotypes of the parents at the steel locus in that experimental mating, although this locus has been maintained as a segregating one by forced heterozygosity in the strain. We therefore contacted Dr. L. C. Stevens, who was able to trace in his 1967 records the parentage of the 6-day embryo in question: the mother was indeed Sl/+, the father wildtype + / + (L. C. Stevens, 1975 , personal communication).
The circulating red blood cells and white blood cells of mosaic mouse no. 1 are predominantly (90% or more) of the 129-strain type, as shown by their strain-specific electrophoretic variants of GPI (Fig. 5) . The hemoglobin produced by the red cells is also chiefly of the diffuse (Hbbd) electrophoretic type, which is the normal adult type of the 129 strain; only a minor fraction is of the C57-b/b single type (Hbbf) (Fig. 6) . Ouchterlony double diffusion analyses of serum immunoglobulin allotypes show only the presence of the 129 strain (Fig. 7) . Serial dilutions indicate that if any C57 allotype were present, it would have to be less than 0.5-1 ,ug/ ml, or a very small fraction of the total of approximately 4 mg/ml of both these classes (IgGI and IgG2a).
Electrophoresis of protein from the urine, for strain-specific MUP variants, revealed presence of both the 129 and C57-b/b strains in mouse no. 1 (Fig. 8) . He must thus have many parenchymal cells of the 129 strain in his liver.
Mouse no. 1 was mated, starting at 7 weeks of age, to females of the C57-b/b strain. He has thus far sired 61 offspring, all normal and all from sperms of the 129 strain, as shown from production of "F1"-like progeny for coat, GPI, and other markers. Some progeny have received the SIJ gene from their father and are phenotypically steel. Whether mouse no. 1 also has any C57-b/b-strain gametes should become clear from further progeny tests.
Mosaic mouse no. 2 was a female from a C57 blastocyst injected with core cells. She was killed for study at 13 days of age. Her coat was entirely like a C57 control, as with previous allophenic mice having only mosaicism of internal tissues (22) (23) (24) (25) . Her circulating red and white blood cells Cell Biblogy: Mintz were also entirely of the C57 GPI type (Fig. 9) ,-a fortunate circumstance because it meant that any 129-type enzyme in homogenates of other tissues reflected the specific tissue genotype and not the blood component. As seen from analyses of the thymus and kidneys (Fig. 9 ), these organs must have contained a substantial proportion of cells derived from the tumor implant. The thymic cells of 129 origin in this particular animal may have been chiefly in the stroma rather than in the lymphocyte population. The entire reproductive tract, although morphologically like that of a normal (X/X) female, contained a minority of the tumor-strain cells (Fig. 9) , which are known (12) to be of male (X/Y) sex chromosome constitution. Comparable cases have previously been de- scribed in X/X X/Y allophenic mice (27) (Figs. 1 and 3 ) of small embryoid bodies have retained their normal diploid chromosome number in vivo (Fig. 4) , as in the tumor of origin (12) . The low incidence of euploidy and the wide variability in chromosome numbers previously found for whole embryoid bodies (10, 11) may, therefore, be due to their rinds of yolk sac cells, which are not multipotential, and/or to inclusion of older cystic embryoid bodies in the preparations. Eight years and almost 200 transplant generations of a tumor that has remained highly malignant have separated the mating of the 129-strain first pair of parents, whose embryo gave rise to the tumor, from recent matings of the C57-or C57-b/b-strain parental pairs whose blastocysts were successfully inoculated with the embryonal carcinoma cells (Fig. 1) . The tumor itself generally kills its host by 3-4 weeks after transplantation. Yet our oldest mosaic animal (mouse no. 1), consisting very largely of tumor-derived cells, is now 11 weeks old and appears healthy and vigorous.
The malignant carcinoma cells, after introduction into normal blastocysts, have given rise to a large variety of normal tissues in three mosaic mice (including one animal still quite incompletely analyzed). The tissues thus far known to have differentiated from the carcinoma implants include melanoblasts, hair follicle dermis, erythrocytes, leucocytes of diverse kinds, liver, thymus, kidneys, and, perhaps most striking of all, sperms. Normal function of these tissues is attested to by production of the 129-strain-specific adult type of hemoglobin, by erythrocytes; immunoglobulins, by plasma cells; MUP, by hepatocytes; glucose-phosphate isomerase, by various tissues; black eumelanin, by melanocytes; elicitation of the phaeomelanin effect, by hair follicle cells; and production of progeny, from eggs fertilized by tumorderived sperms. According to conventional classifications, all germ layers are included in these differentiations. However, as the old germ-layer concept undervalues flexibility in development (28, 7) , it is perhaps more relevant to emphasize that the results show differentiation of teratocarcinoma cells into many developmentally unrelated tissues. Some of these tissues, e.g., liver, thymus, and kidney, have never been seen in mouse teratomas (ref. 5; and L. C. Stevens, 1975, personal communication In the present experiments, orderly expression of many genes (e.g., immunoglobulin, hemoglobin, MUP, agouti genes) has occurred in vio after they had been "silent" or undetected in the tumors for 8 years, as well as in cultures of teratocarcinoma cells. Differentiation has also uncovered, as an organismic phenotype, a hitherto cryptic gene, steel, whose presence was unsuspected. Thus, embryonal carcinoma cells from embryoid body cores (or, preferably, from a transplantable core-cell line) offer new possibilities for studies of mammalian regulatory systems: The carcinoma cells could first be experimentally mutagenized and selected during a brief in vitro sojourn and then "cycled" through mice via blastocyst injections. Participation in differentiation of a mosaic individual would permit developmental and biochemical analyses of the mutations; conversion of some cells to gametes would enable genetic analysis and mapping of the mutated regions through recombination and segregation during meiosis. Among the advantages over conventional germ-cell mutagenesis in vivo are the possibility of subjecting mutagenized cells to selective screens; of bypassing the problems of sterility and dominant lethals; of obtaining mutant clones of desired size; and of biochemically analyzing early-stage mutants.
These studies also offer a new means of analyzing the basis for malignancy. The capacity of embryonal carcinoma cells to form normally functioning adult tissues demonstrates that conversion to neoplasia did not involve structural changes in the genome, but rather a change in gene expression (7, 31) . Maintenance of a proliferative stem-cell way of life, hence commitment to malignancy, appears to have been due solely to an organizational disturbance during development. Its complete reversibility in a normal environment is unequivocal, i.e., not attributable to selection for nonmalignant cells. The results thus support the hypotheses of Pierce (2) and Stevens (1, 12) concerning the origin of these tumors. A comparable nonmutational basis for neoplastic conversion, involving changes in gene expression due to tissue disorganization, may apply to some malignancies of partially specialized stem cells of particular tissues.
Note Added in Proof. More recent analyses have disclosed additional normal mosaics: two postnatal males and two fetuses with carcinoma-derived cells in some tissues, including heart and skeletal muscle in one case. Tumor-derived cells were also detected in three normal placentas (from fetuses of solely blastocyst origin).
This work was supported by U.S. Public Health Service Grants HD-01646, CA-06927, and RR-05539, and by an appropriation from the Commonwealth of Pennsylvania.
